An assessment of dyssynchrony is usually undertaken prior to CRT in order to identify patients who are likely to improve – and avoid implanting a pacemaker in those unlikely to benefit.

Pacemakers and cardiac resynchronization therapy pacemakers are small, battery-powered devices that are surgically implanted ...

Methods: We exposed 12 ICDs and eight CRT-ICDs to 400 cGy of scatter radiation ... 5 Gy Vitals done before and after each treatment with pacemaker-dependent ECG with first treatment Cardiologist ...

EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...

Surge in geriatric population along with rise in prevalence of cardiovascular diseases (CVDs), increase in technological advancements in the CRT pacemakers and CRT defibrillators, and rise in ...

The US Food & Drug Administration (FDA) has approved EBR Systems' (ASX:EBR) WISE wireless pacemaker device, thus opening a ...

Patients with high procedural risk for LV lead placement Patients with leadless pacemakers* who need CRT, yet are often poor candidates for conventional upgrades In short: WiSE brings CRT to more ...